Investors with a lot of money to spend have taken a bearish stance on Recursion Pharmaceuticals RXRX.
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RXRX, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Recursion Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 60%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $41,640, and 9, calls, for a total amount of $471,855.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $12.0 for Recursion Pharmaceuticals, spanning the last three months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of Recursion Pharmaceuticals stands at 3202.67, with a total volume reaching 6,136.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Recursion Pharmaceuticals, situated within the strike price corridor from $5.0 to $12.0, throughout the last 30 days.
Recursion Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | CALL | SWEEP | BULLISH | 01/15/27 | $2.15 | $1.95 | $2.14 | $12.00 | $106.0K | 819 | 500 |
| RXRX | CALL | TRADE | BULLISH | 01/15/27 | $2.15 | $1.95 | $2.1 | $12.00 | $105.0K | 819 | 1.0K |
| RXRX | CALL | SWEEP | BEARISH | 03/21/25 | $1.9 | $1.8 | $1.8 | $5.00 | $55.8K | 1.0K | 494 |
| RXRX | CALL | SWEEP | BULLISH | 04/25/25 | $0.55 | $0.5 | $0.55 | $7.50 | $53.9K | 96 | 1.1K |
| RXRX | CALL | TRADE | BEARISH | 06/20/25 | $0.85 | $0.8 | $0.8 | $8.00 | $41.6K | 8.1K | 229 |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Current Position of Recursion Pharmaceuticals
- Trading volume stands at 15,125,091, with RXRX's price up by 8.17%, positioned at $6.87.
- RSI indicators show the stock to be may be approaching oversold.
- Earnings announcement expected in 52 days.
What Analysts Are Saying About Recursion Pharmaceuticals
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $6.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Leerink Partners persists with their Market Perform rating on Recursion Pharmaceuticals, maintaining a target price of $6.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Recursion Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
